| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/06/2000 | EP1032566A2 Method for the preparation of citalopram |
| 09/06/2000 | EP1032561A1 Substituted oximes as neurokinin antagonists |
| 09/06/2000 | EP1032559A1 Aminoalkylphenol derivatives and related compounds |
| 09/06/2000 | EP1032556A1 Pharmaceutically active compounds and methods of use |
| 09/06/2000 | EP1032555A1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 09/06/2000 | EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 09/06/2000 | EP1032403A1 Nutritional supplement for cerebral metabolic insufficiencies |
| 09/06/2000 | EP1032402A1 Citicoline to treat motor neuron diseases and demyelinating diseases |
| 09/06/2000 | EP1032398A1 Methods for treating postmenopausal women using ultra-low doses of estrogen |
| 09/06/2000 | EP1032397A1 Testosterone inhibitors and use for the protection of neurons |
| 09/06/2000 | EP1032393A1 QUINOLINE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 09/06/2000 | EP1032391A1 Spheroids containing tiagabine, preparation process and pharmaceutical compositions |
| 09/06/2000 | EP1032389A1 CHRONIC, BOLUS ADMINISTRATION OF D-threo METHYLPHENIDATE |
| 09/06/2000 | EP1032377A1 Substituted 2-aminoacetamides and the use thereof |
| 09/06/2000 | EP1032368A1 Iontophoretic devices comprising piperidin derivatives |
| 09/06/2000 | EP0719145B1 Nitric oxide donor composition for treatment of anal disorders |
| 09/06/2000 | EP0711134B1 Medicinal for protection from neurological damage |
| 09/06/2000 | EP0697864B1 Use of ferrioxamine b in the treatment os septic shock |
| 09/06/2000 | EP0665844B1 Substituted benzylaminoquinuclidines as substance p antagonists |
| 09/06/2000 | CN1265675A Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265674A 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265673A Dipeptide compounds which inhibit leukocyte adhesion medicated by VLA-4 |
| 09/06/2000 | CN1265670A Dipeptide and related compounds which inhibit leukocyte adhesion medicated by VLA-4 |
| 09/06/2000 | CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265668A Subtsituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265660A 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives |
| 09/06/2000 | CN1265658A 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application |
| 09/06/2000 | CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265654A 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring |
| 09/06/2000 | CN1265652A 2-acrylaminopropanamines as tachykinin receptor antagonists |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/06/2000 | CN1265600A Cloning pigs using donor nuclei from differentiated cells |
| 09/06/2000 | CN1265599A Cloning using donor nuclei from non-serum starved, differentiated cells |
| 09/06/2000 | CN1265593A Novel process for manufacturing paroxetine solid dispersions |
| 09/06/2000 | CN1265586A Use of a specific antagonist of 5HTz recepotors for preparing medicine useful for treating sleep-disordered breathing |
| 09/06/2000 | CN1056180C Drink and manufacture thereof |
| 09/06/2000 | CN1056144C New use of 6-heterocyclic-4-amino-3,4,5-tetrahydrobenz (CD) indoles compound |
| 09/06/2000 | CN1056141C 哌嗪衍生物 Piperazine derivatives |
| 09/06/2000 | CN1056080C Chinese medicine for curing trigeminal neuralgia and its prepn. |
| 09/06/2000 | CN1056074C Tengxiling fumigant |
| 09/06/2000 | CN1056066C Health medicine able to help somebody to sleep |
| 09/05/2000 | US6114568 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 09/05/2000 | US6114530 Isoquiolinamines and phthalazinamines useful in treating stress related disorderes such as post traumatic stress disorder as well as depression, headache and anxiety |
| 09/05/2000 | US6114391 α-amino acid amides, preparation thereof and the therapeutical use thereof |
| 09/05/2000 | US6114388 Monofunctional and/or polyfunctional polylysine conjuages |
| 09/05/2000 | US6114372 Matrix metalloproteinase (mmp); tumor necrosis factor(tnf); compounds such as n2-((2s)-acetylmercapto)acetyl-5-phthalimidopentanoyl)-n1-((4 -methoxybenzene)sulphonyl)-n1-(phenylmethyl)hydrazine |
| 09/05/2000 | US6114365 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 09/05/2000 | US6114361 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
| 09/05/2000 | US6114359 Endothelin receptor antagonists |
| 09/05/2000 | US6114356 Method for treating gastrointestinal disorders using (+) norcisapride |
| 09/05/2000 | US6114347 Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors |
| 09/05/2000 | US6114346 Treating sleep disorders using desloratadine |
| 09/05/2000 | US6114338 Heterocyclic compounds |
| 09/05/2000 | US6114334 Piperazine derivatives as therapeutic agents |
| 09/05/2000 | US6114326 Sleep disorders |
| 09/05/2000 | US6114317 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 09/05/2000 | US6114304 Administering an amylin agonist such as pramlintide or pramlintide acetate; reducing gastric motility or delaying gastric emptying |
| 09/05/2000 | US6113949 Weight control product and method of treating hyperlipidemia and increasing vigor with said product |
| 09/05/2000 | US6113947 Controlled release microencapsulated NGF formulation |
| 09/05/2000 | US6113944 Mixing with excipients and compression into tablets |
| 09/05/2000 | US6113915 Methods for treating pain |
| 09/05/2000 | US6113906 Water-soluble non-antigenic polymer linkable to biologically active material |
| 09/05/2000 | US6113905 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 09/05/2000 | US6113904 Polypeptide with amino acid sequences |
| 09/05/2000 | US6113899 Antagonists of chaperonin 10 |
| 09/05/2000 | US6113527 3,3-bis-hydroxymethyl-7-(cis-4-isopropyl-cyclohexyl)-1-phenyl -1,7-diaza-spiro-(3.5)nonane-2-one, for example; agonists of the orphanin fq (ofq) receptor; useful in the treatment of psychiatric, neurological and physiological disorders |
| 09/05/2000 | CA2188662C New method of treatment |
| 08/31/2000 | WO2000050872A2 A system for cell-based screening |
| 08/31/2000 | WO2000050641A1 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION |
| 08/31/2000 | WO2000050639A2 Gene sequence variations with utility in determining the treatment of disease |
| 08/31/2000 | WO2000050568A2 Transplantation of haematopoietic cells |
| 08/31/2000 | WO2000050562A2 Dna encoding snorf25 receptor |
| 08/31/2000 | WO2000050453A1 A novel inhibitor of programmed cell death |
| 08/31/2000 | WO2000050451A2 Protein (tp) that is involved in the development of the nervous system |
| 08/31/2000 | WO2000050447A1 Carbohydrate epitope mimic peptides and uses thereof |
| 08/31/2000 | WO2000050421A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments |
| 08/31/2000 | WO2000050420A1 6-substituted-7- heteroquinoxaline carboxylic acid derivatives and addition salts thereof and processes for the preparation of both |
| 08/31/2000 | WO2000050416A1 6-substituted heteroquinolinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both |
| 08/31/2000 | WO2000050401A1 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists |
| 08/31/2000 | WO2000050400A1 2-aminopyridines containing fused ring substituents |
| 08/31/2000 | WO2000050398A2 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists |
| 08/31/2000 | WO2000050391A1 Novel sulfonamide compounds and uses thereof |
| 08/31/2000 | WO2000050380A1 Monoamine reuptake inhibitors for treatment of cns disorders |
| 08/31/2000 | WO2000050079A1 Tumor necrosis factor antagonists for the treatment of neurological disorders |
| 08/31/2000 | WO2000050028A1 Compositions for the treatment of pain |
| 08/31/2000 | WO2000050017A2 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases |
| 08/31/2000 | WO2000050014A2 Phenytoin sodium pharmaceutical compositions |
| 08/31/2000 | WO2000028029A3 Cell surface glycoproteins |
| 08/31/2000 | WO2000027849A3 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
| 08/31/2000 | WO2000027382A3 Combination of a gaba-a alpha 5 inverse agonist and cox-2 inhibitor, nsaid, estrogen or vitamin e |
| 08/31/2000 | WO2000025753A3 Controlled delivery of active agents |
| 08/31/2000 | WO2000023055A9 Oral pulsed dose drug delivery system |
| 08/31/2000 | WO2000020601A9 Polyketide synthase enzymes and recombinant dna constructs therefor |
| 08/31/2000 | WO2000007996A3 Pyrazoles as estrogen receptor modulators |
| 08/31/2000 | WO2000001375A3 Calcium channel blockers |
| 08/31/2000 | DE19908423A1 An der Entwicklung des ZNS beteiligtes Protein (TP) The development of the CNS involved protein (TP) |
| 08/31/2000 | DE19906979A1 Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Nikotinabhängigkeit Pharmaceutical composition containing deoxypeganine for the treatment of nicotine dependence |
| 08/31/2000 | DE19906974A1 Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung des Alkoholismus Pharmaceutical composition containing deoxypeganine for the treatment of alcoholism |
| 08/31/2000 | DE10008042A1 Neurokinin-1-Rezeptorantagonisten Neurokinin-1 receptor antagonists |
| 08/31/2000 | CA2366919A1 Novel sulfonamide compounds and uses thereof |